FibroBiologics, Inc. (FBLG) stock

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30

$0.93−0.04 (-4.21%)

Close on Nov 13, 2026Market cap $6.17MP/E –Yield –

FibroBiologics gross margin

Gross margin is gross profit as a percentage of revenue.

FibroBiologics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?